VVUS and OREX Related Headlines

Go Back

Sep 11, 2014 09:19AM Orexigen Therapeutics (OREX) Price Target Raised to $14-$15 at Wells Fargo
Sep 11, 2014 08:58AM VIVUS (VVUS), Arena (ARNA) Active Following FDA Approval of Orexigen's (OREX) Weight-Loss Drug
Aug 1, 2014 11:53AM Arena Pharma (ARNA) Peers Drop in Sympathy Following Q2 Results (OREX) (VVUS)
Jul 7, 2014 11:56AM Arena Pharma (ARNA) Peers Trade Lower in Sympathy (OREX) (VVUS)
Jun 11, 2014 08:03AM Wells Fargo Comments on Orexigen Therapeutics (OREX) PDUFA Data Change
Feb 24, 2014 05:32PM Orexigen (OREX), Arena (ARNA) in Focus Following VIVUS' (VVUS) Q4 Results
Jan 10, 2014 02:34PM WallachBeth Starts Orexigen (OREX) at Buy; Sees Contrave With Edge Over Peers (ARNA) (VVUS)
Dec 30, 2013 07:57AM VIVUS, Inc. (VVUS) Sees CHMP Feedback on Qsiva Resubmission as 'Generally Positive'
Dec 12, 2013 08:24AM Analyst Sees Positive Reimbursement Trends for Obesity Drugs (VVUS) (ARNA) (OREX)
Nov 27, 2013 12:04PM Recent Contrave Data is Positive for Orexigen's (OREX) Other Weight-Loss Candidate - Analyst

VVUS and OREX Related Press Releases

Go Back

VVUS and OREX Related SEC Filings

Go Back

Dec 30, 2013 07:57AM VIVUS, Inc. (VVUS) Sees CHMP Feedback on Qsiva Resubmission as 'Generally Positive'